CAS Registry Number raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-03 and is reviewed periodically as new material appears.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
The OECD releases about 600 books and over 400 papers yearly on topics spanning public policy. The publications are updated to the OECD.org. Most books are published in English and French. The OECD flagship titles include:
== Transcriptomics == Different Hydra cell types express gene families of different evolutionary ages. Progenitor cells (stem cells, neuron and nematocyst precursors, and germ cells) express genes from families that predate metazoans. Among differentiated cells some express genes from families that date from the base of metazoans, like gland and neuronal cells, and others express genes from newer families, originating from the base of cnidaria or medusozoa, like nematocysts. Interstitial cells contain translation factors with a function that has been conserved for at least 400 million years.
== Software == Web-based Structural Analysis tool for any uploaded PDB file, producing Ramachandran plots, computing dihedral angles and extracting sequence from PDB Archived 2016-03-05 at the Wayback Machine Web-based tool showing Ramachandran plot of any PDB entry MolProbity web service that produces Ramachandran plots and other validation of any PDB-format file SAVES (Structure Analysis and Verification) — uses WHATCHECK, PROCHECK, and does its own internal Ramachandran Plot STING Pymol with the DynoPlot extension VMD, distributed with dynamic Ramachandran plot plugin WHAT CHECK, the stand-alone validation routines from the WHAT IF software UCSF Chimera, found under the Model Panel. Sirius Swiss PDB Viewer Archived 2019-01-18 at the Wayback Machine TALOS Zeus molecular viewer — found under "Tools" menu, high quality plots with regional contours Procheck Neighbor-Dependent and Neighbor-Independent Ramachandran Probability Distributions See also PDB for a list of similar software.
=== Truett's Grill === In 1996, the first Truett's Grill was opened in Morrow, Georgia. The second location opened in 2003 in McDonough, Georgia, and a third location opened in 2006 in Griffin, Georgia. Similar to the Chick-fil-A Dwarf Houses, these independently owned restaurants offer traditional, sit-down dining and expanded menu selections in a diner-themed restaurant. In 2017, Chick-fil-A demolished several Dwarf House locations to replace them with Truett's Grill locations.
Sources: en.wikipedia.org
== After WWII == In 1968, Victor Saxl died and Eva moved to Santiago, Chile, to live with her brother, her only living relative. There she would remain vigilant as an advocate for people with Type 1 diabetes. Eva Saxl died in 2002 in Santiago. The Saxls' story was dramatized by the 1956–1958 CBS television show Telephone Time in an episode titled "Time Bomb".
The absence of the enzyme has no negative effect on growth and the bacteria show no phenotypeic differences, with the exception that lactobacillic acid or other cyclopropanoic acids do not occur among the fatty acids present. A similar experiment was carried out with artificially produced mutants of Brucella abortus. The bacteria are still able to multiply in macrophages, so lactobacillic acid has no effect on the intracellular life cycle. However, if the bacteria are cultivated in a culture medium with a low pH value and high osmolarity, less growth can be observed compared to the unmodified cells. These conditions can be transferred to the survival of B. abortus in the environment, where an acidic environment with high osmolarity can also occur. The mutants that do not produce lactobacillic acid have poorer chances of survival there and consequently cannot be transferred to a host as easily as is the case with a smear infection, for example. The study of the promoter of the cfa gene also shows that expression is promoted by low pH and high osmolarity, i.e. the enzyme CFA synthase is formed under these conditions. From the point of view of energy metabolism, the formation of the cyclopropane ring in lactobacillic acid means a relatively high energy expenditure for the cell. The S adenosylmethionine, which acts as a carrier of the methylene group, must then be regenerated from S adenosylhomocysteine. This is associated with the hydrolytic cleavage of three ATP molecules per molecule.
Buc-ee's has a beaver mascot named Buc-ee that it uses for various promotional and merchandising purposes. He is an anthropomorphic beaver wearing a baseball cap and t-shirt. The character's design in Buc-ee's's logo was made using a drawing guide from Preston Blair's book Advanced Animation. Statues of Buc-ee can be found in many locations of the gas station, and one is even displayed at a museum in Austin, Texas. Buc-ee also has a mascot costume, which is used for promotional materials and to advertise store openings. Buc-ee's is very litigious when it comes to their mascot, as they have filed several lawsuits against companies they deem to be infringing on his design.
Vance describes his upbringing and family background while growing up in Middletown, Ohio, where his mother and her family had moved after World War II from Breathitt County, Kentucky. Vance states that their Appalachian culture valued traits such as loyalty and love of country despite family violence and verbal abuse. Vance recounts his grandparents' alcoholism as well as his mother's history of drug addictions and failed relationships. Vance's grandparents reconciled and became his guardians. His strict but loving grandmother pushed Vance, who went on to complete undergraduate studies at Ohio State University and earned a Juris Doctor degree from Yale Law School. Vance raises questions about the responsibility of his family and local people for their misfortunes. Vance suggests that hillbilly culture fosters social disintegration and economic insecurity in Appalachia. He cites a personal experience where, while working as a grocery store cashier, he saw welfare recipients with cell phones when he could not afford one. Vance's antipathy toward those who seemed to profit from poor behavior while he struggled is presented as a rationale for Appalachia's political swing from voting Democratic to a strong Republican affiliation. Vance tells stories highlighting the lack of work ethic of the local people, including the story of a man who quit his job after expressing dislike over his work hours, and a co-worker with a pregnant girlfriend who skipped work unexcused.
Manifold are thy shapings, Providence! / Many a hopeless matter gods arrange / What we expected never came to pass / What we did not expect the gods brought to bear / So have things gone, this whole experience through! This deliberate murder of her children by Medea appears to be Euripides' invention, although some scholars believe Neophron created this alternate tradition. Her filicide would go on to become the standard for later writers. Pausanias, writing in the late 2nd century AD, records five different versions of what happened to Medea's children after reporting that he has seen a monument for them while traveling in Corinth.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.